Literature DB >> 15303790

Pustular psoriasis induced by infliximab.

Marzieh Thurber1, Adrienne Feasel, John Stroehlein, Sharon R Hymes.   

Abstract

Pustular psoriasis is an uncommon variant of psoriasis characterized by widespread pustules on an erythematous background. Recent reports document the efficacy of immunobiologic agents such as infliximab in the treatment of pustular psoriasis. We present a patient that developed cutaneous and pathologic changes consistent with pustular psoriasis while receiving treatment with infliximab for chronic ulcerative colitis. More long-term studies need to be conducted in order to fully understand this paradoxical reaction as well as the mechanism of action and side effect profiles of infliximab and other immunobiologic agents.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15303790

Source DB:  PubMed          Journal:  J Drugs Dermatol        ISSN: 1545-9616            Impact factor:   2.114


  11 in total

1.  New onset or exacerbation of psoriatic skin lesions in patients with definite rheumatoid arthritis receiving tumour necrosis factor alpha antagonists.

Authors:  S Kary; M Worm; H Audring; D Huscher; M Renelt; H Sörensen; E Ständer; U Maass; H Lee; W Sterry; G-R Burmester
Journal:  Ann Rheum Dis       Date:  2005-09-08       Impact factor: 19.103

2.  Psoriasis after treatment of juvenile idiopathic arthritis with etanercept.

Authors:  R Peek; R Scott-Jupp; H Strike; J Clinch; A V Ramanan
Journal:  Ann Rheum Dis       Date:  2006-09       Impact factor: 19.103

3.  A medical conundrum: onset of psoriasis in patients receiving anti-tumour necrosis factor agents.

Authors:  C Ritchlin; F Tausk
Journal:  Ann Rheum Dis       Date:  2006-12       Impact factor: 19.103

4.  [Possibilities and limits for treating psoriasis with biologics. Case reports].

Authors:  A Süss; A Colsman; J C Simon; M Sticherling
Journal:  Hautarzt       Date:  2009-01       Impact factor: 0.751

5.  Psoriasis onset during infliximab treatment: description of two cases.

Authors:  Alessandro Volpe; Paola Caramaschi; Antonio Carletto; Sara Pieropan; Lisa Maria Bambara; Domenico Biasi
Journal:  Rheumatol Int       Date:  2006-10       Impact factor: 2.631

Review 6.  TNF receptor 2 pathway: drug target for autoimmune diseases.

Authors:  Denise Faustman; Miriam Davis
Journal:  Nat Rev Drug Discov       Date:  2010-05-21       Impact factor: 84.694

Review 7.  [Infliximab. Role in the treatment of psoriasis].

Authors:  R Mössner; K Reich
Journal:  Hautarzt       Date:  2005-09       Impact factor: 0.751

8.  Paradoxical SAPHO syndrome observed during anti-TNFα therapy for Crohn's disease.

Authors:  Hitoshi Amano; Reikei Matsuda; Tomohiko Shibata; Daisuke Takahashi; Shinichiro Suzuki
Journal:  Biologics       Date:  2017-05-22

9.  The changing face of spondyloarthropathies under TNF α blockade.

Authors:  Ori Elkayam; Irena Litinsky; David Levartovsky; Dan Caspi
Journal:  Open Rheumatol J       Date:  2008-11-14

10.  Manifestation of palmoplantar pustulosis during or after infliximab therapy for plaque-type psoriasis: report on five cases.

Authors:  Rotraut Mössner; Diamant Thaci; Johannes Mohr; Sylvie Pätzold; Hans Peter Bertsch; Ullrich Krüger; Kristian Reich
Journal:  Arch Dermatol Res       Date:  2008-02-01       Impact factor: 3.017

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.